Glucagon Receptor Knockout Mice Display Increased Insulin Sensitivity and Impaired β-Cell Function

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Diabetes

• Publication date

  2006-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2337/db06-0307PMID 17130493
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neuropeptides and the Regulation of Islet Function

  2006cited by this paper
• Reduction in glucagon receptor expression by an antisense oligonucleotide ameliorates diabetic syndrome in db/db mice.

  2004cited by this paper
• Hepatic and glucagon-like peptide-1-mediated reversal of diabetes by glucagon receptor antisense oligonucleotide inhibitors.

  2004cited by this paper
• Both fasting glucose production and disappearance are abnormal in people with "mild" and "severe" type 2 diabetes.

  2004cited by this paper
• Increased insulin sensitivity is associated with reduced insulin and glucagon secretion and increased insulin clearance in man.

  2003cited by this paper
• Lower blood glucose, hyperglucagonemia, and pancreatic α cell hyperplasia in glucagon receptor knockout mice

  2003influential reference
• Glycemic control in mice with targeted disruption of the glucagon receptor gene.

  2002cited by this paper
• Differential impairment of glucagon responses to hypoglycemia, neuroglycopenia, arginine, and carbachol in alloxan-diabetic mice.

  2002cited by this paper
• Assessment of hepatic insulin action in obese type 2 diabetic patients.

  2001cited by this paper
• Contribution to glucose tolerance of insulin-independent vs. insulin-dependent mechanisms in mice.

  2001cited by this paper
• Impaired glucose tolerance (IGT) is associated with reduced insulin-induced suppression of glucagon concentrations

  2001cited by this paper
• Glucose intolerance is predicted by low insulin secretion and high glucagon secretion: outcome of a prospective study in postmenopausal Caucasian women

  2000cited by this paper
• PACAP contributes to insulin secretion after gastric glucose gavage in mice.

  2000cited by this paper
• Lack of suppression of glucagon contributes to postprandial hyperglycemia in subjects with type 2 diabetes mellitus.

  2000cited by this paper
• Dose-related effects of GLP-1 on insulin secretion, insulin sensitivity, and glucose effectiveness in mice.

  1999cited by this paper
• Dose-related effects of GLP-1 on insulin secretion, insulin sensitivity, and glucose effectiveness in mice.

  1999cited by this paper
• Role of free fatty acids and glucagon in the peripheral effect of insulin on glucose production in humans.

  1998cited by this paper
• Defective prohormone processing and altered pancreatic islet morphology in mice lacking active SPC2.

  1997cited by this paper
• Glucagon and its Family Revisited

  1995cited by this paper
• Proglucagon processing in porcine and human pancreas.

  1994cited by this paper
• Immunoneutralization of endogenous glucagon with monoclonal glucagon antibody normalizes hyperglycaemia in moderately streptozotocin-diabetic rats

  1994cited by this paper
• Quantification of the Relationship Between Insulin Sensitivity and β-Cell Function in Human Subjects: Evidence for a Hyperbolic Function

  1993cited by this paper
• Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting beta-cells.

  1993cited by this paper
• Effects of small changes in glucagon on glucose production during a euglycemic, hyperinsulinemic clamp.

  1991cited by this paper
• Obesity and insulin resistance in humans: a dose-response study.

  1990cited by this paper
• Both amidated and nonamidated forms of glucagon-like peptide I are synthesized in the rat intestine and the pancreas.

  1990cited by this paper
• Documentation of hyperglucagonemia throughout the day in nonobese and obese patients with noninsulin-dependent diabetes mellitus.

  1987cited by this paper
• Role of Hyperglucagonemia in Maintenance of Increased Rates of Hepatic Glucose Output in Type II Diabetics

  1987cited by this paper
• Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose.

  1981cited by this paper
• Method for the Isolation of Intact Islets of Langerhans from the Rat Pancreas

  1967cited by this paper

• Uncoupling Insulin Sensitivity From Longevity: A Sex‐Dependent Effect of Hepatic Glucagon Signaling

  2026cites this paper
• Loss of Slc39a5 in α-cells impairs glucose metabolism by chronically increasing glucagon.

  2025cites this paper
• Activin B improves glucose metabolism via induction of Fgf21 and hepatic glucagon resistance

  2025cites this paper
• Glucagon-like peptide-1 receptor modulates cerebrospinal fluid secretion and intracranial pressure in rats

  2025influential citation
• GLP-1/GIP/GCG receptor triagonist (IUB447) enhances insulin secretion via GLP-1 receptor and Gαq signalling pathway in mice

  2025cites this paper
• Liver-specific glucagon dysfunction promotes PP-cell hyperplasia and formation of glucagon and PP double-positive cells

  2025cites this paper
• Chronic late gestation fetal hyperglucagonaemia results in lower insulin secretion, pancreatic mass, islet area and beta‐ and α‐cell proliferation

  2024cites this paper
• Research advances in understanding crosstalk between organs and pancreatic β‐cell dysfunction

  2024cites this paper
• Human subjects with impaired beta-cell function and glucose tolerance have higher levels of intra-islet intact GLP-1.

  2024cites this paper
• Distinct physiological characteristics and altered glucagon signaling in GHRH knockout mice: Implications for longevity

  2023cites this paper
• Pancreatic β-cell heterogeneity in adult human islets and stem cell-derived islets

  2023cites this paper
• Glucagon in type 2 diabetes: Friend or foe?

  2023cites this paper
• Endosomal trafficking in metabolic homeostasis and diseases

  2022cites this paper
• Crosstalk Between Insulin- and Glucagon-Receptor Signaling in the Hepatocyte.

  2022cites this paper
• Temporal Patterns of Glucagon and Its Relationships with Glucose and Insulin following Ingestion of Different Classes of Macronutrients

  2022cites this paper
• Pancreatic alpha cells and glucagon secretion: Novel functions and targets in glucose homeostasis.

  2022cites this paper
• Insights into the Role of Glucagon Receptor Signaling in Metabolic Regulation from Pharmacological Inhibition and Tissue-Specific Knockout Models

  2022cites this paper
• Measurement of Pulsatile Insulin Secretion: Rationale and Methodology

  2021cites this paper
• Atypical Antipsychotics and Metabolic Syndrome: From Molecular Mechanisms to Clinical Differences

  2021cites this paper
• Intra-islet glucagon confers β-cell glucose competence for first-phase insulin secretion and favors GLP-1R stimulation by exogenous glucagon

  2021cites this paper
• Naturally occurring mutations in G protein-coupled receptors associated with obesity and type 2 diabetes mellitus.

  2021cites this paper
• Glucagon Potentiates Insulin Secretion Via β-Cell GCGR at Physiological Concentrations of Glucose

  2021influential citation
• Altered islet prohormone processing: A cause or consequence of diabetes?

  2021cites this paper
• Global Transcriptomic Analysis of Zebrafish Glucagon Receptor Mutant Reveals Its Regulated Metabolic Network

  2020cites this paper
• Title: Engineering Functional Pseudo-Islets of Defined Sizes from Primary Murine Cells Using PEG Microwell Devices Authors/Affiliations

  2020cites this paper
• Small Molecule-Induced Pancreatic β-Like Cell Development: Mechanistic Approaches and Available Strategies

  2020cites this paper
• Engineering Functional Pseudo-Islets of Defined Sizes from Primary Murine Cells Using PEG Microwell Devices

  2020cites this paper
• Characterization of a naturally occurring mutation V368M in the human glucagon receptor and its association with metabolic disorders.

  2020cites this paper
• The mediation by GLP-1 receptors of glucagon-induced insulin secretion revisited in GLP-1 receptor knockout mice.

  2020cites this paper
• Pancreatic α-cells - The unsung heroes in islet function.

  2020cites this paper
• Glucagon and insulin secretion, insulin clearance, and fasting glucose in GIP receptor and GLP-1 receptor knockout mice.

  2019cites this paper
• The Local Paracrine Actions of the Pancreatic α-Cell

  2019cites this paper
• Chapter 2 Comparative Analysis of Islet Development

  2019cites this paper
• Glucagon Receptor Signaling and Glucagon Resistance

  2019cites this paper
• GLP-2 receptor signaling controls circulating bile acid levels but not glucose homeostasis in Gcgr−/− mice and is dispensable for the metabolic benefits ensuing after vertical sleeve gastrectomy

  2018cites this paper
• Insulin Secretion Depends on Intra-islet Glucagon Signaling.

  2018cites this paper
• Design principles of the paradoxical feedback between pancreatic alpha and beta cells

  2018cites this paper
• Deletion of the glucagon receptor gene before and after experimental diabetes reveals differential protection from hyperglycemia

  2018cites this paper
• A Hepatocyte FOXN3-α Cell Glucagon Axis Regulates Fasting Glucose.

  2018cites this paper
• 1,25-Dihydroxyvitamin D3 protects obese rats from metabolic syndrome via promoting regulatory T cell-mediated resolution of inflammation

  2018cites this paper
• Glucagon increases insulin levels by stimulating insulin secretion without effect on insulin clearance in mice

  2017cites this paper
• The New Biology and Pharmacology of Glucagon.

  2017cites this paper
• MiR-184 expression is regulated by AMPK in pancreatic islets

  2017cites this paper
• Co-culture of clonal beta cells with GLP-1 and glucagon-secreting cell line impacts on beta cell insulin secretion, proliferation and susceptibility to cytotoxins.

  2016cites this paper
• Comparative Analysis of Islet Development

  2016cites this paper
• Glucagon actions on the kidney revisited: possible role in potassium homeostasis.

  2016cites this paper
• Heparanase Overexpression Induces Glucagon Resistance and Protects Animals From Chemically Induced Diabetes

  2016cites this paper
• Endogenous GIP ameliorates impairment of insulin secretion in proglucagon-deficient mice under moderate beta cell damage induced by streptozotocin

  2016cites this paper
• Chapter 17 – Clinical Remission and Survival in Diabetic Cats: What Has Changed Over the Last Decade

  2016cites this paper
• Newly uncovered novel properties of heparanase in the heart and pancreas

  2016cites this paper
• Evidence for time dependent variation of glucagon secretion in mice.

  2016influential citation
• An optical method to evaluate both mass and functional competence of pancreatic α- and β-cells

  2016cites this paper
• Physiology of proglucagon peptides: role of glucagon and GLP-1 in health and disease.

  2015cites this paper
• Glucagon action in the dorsal vagal complex and the regulation of glucose homeostasis during high-protein feeding

  2015cites this paper
• New insights into the architecture of the islet of Langerhans: a focused cross-species assessment

  2015cites this paper
• Glucagon--Early breakthroughs and recent discoveries.

  2015cites this paper
• Physiological and pathophysiological control of glucagon secretion by pancreatic α-cells

  2015cites this paper
• Small molecule glucagon receptor antagonists: a patent review (2011 – 2014)

  2015cites this paper
• The roles of pancreatic hormones in regulating pancreas development and beta cell regeneration

  2015cites this paper
• FFAR3 modulates insulin secretion and global gene expression in mouse islets

  2015cites this paper
• PTEN Deletion in Pancreatic α-Cells Protects Against High-Fat Diet–Induced Hyperglucagonemia and Insulin Resistance

  2014cites this paper
• Risk-associated coding synonymous SNPs in type 2 diabetes and neurodegenerative diseases: genetic silence and the underrated association with splicing regulation and epigenetics.

  2014cites this paper
• Blockade of Na+ Channels in Pancreatic α-Cells Has Antidiabetic Effects

  2014cites this paper
• Differential AMPK phosphorylation by glucagon and metformin regulates insulin signaling in human hepatic cells.

  2014cites this paper
• Nutrient regulation of glucagon secretion: involvement in metabolism and diabetes

  2014cites this paper
• N-Glycan Remodeling on Glucagon Receptor Is an Effector of Nutrient Sensing by the Hexosamine Biosynthesis Pathway*

  2014cites this paper
• Something old, something new and something very old: drugs for treating type 2 diabetes

  2014cites this paper
• Effects of short-term chemical ablation of glucagon signalling by peptide-based glucagon receptor antagonists on insulin secretion and glucose homeostasis in mice.

  2014cites this paper
• Factors affecting insulin-regulated hepatic gene expression.

  2014cites this paper
• Transdifferentiation of pancreatic α-cells into insulin-secreting cells: From experimental models to underlying mechanisms.

  2014cites this paper
• Fluorescence recovery after photobleaching reveals regulation and distribution of connexin36 gap junction coupling within mouse islets of Langerhans

  2014cites this paper
• Role of the Glucagon and Glucagon-like Peptides in Pancreatic Beta Cell and Cardiovascular Function

  2014cites this paper
• The role of chemokine ligand 5 and GPR75 on islet function

  2014cites this paper
• In vivo and in vitro analysis of Dll1 and Pax6 function in the adult mouse pancreas

  2014cites this paper
• Gastrointestinal Regulation of Energy Balance

  2014cites this paper
• Current Insights and New Perspectives on the Roles of Hyperglucagonemia in Non-Insulin–Dependent Type 2 Diabetes

  2013cites this paper
• Alpha cells come of age.

  2013cites this paper
• Intra-islet glucagon secretion and action in the regulation of glucose homeostasis

  2013influential citation
• Gut-Brain Communication in the Regulation of System Metabolism

  2013cites this paper
• Oxyntomodulin increases intrinsic heart rate through the glucagon receptor

  2013cites this paper
• Ectopic Expression of GIP in Pancreatic β-Cells Maintains Enhanced Insulin Secretion in Mice With Complete Absence of Proglucagon-Derived Peptides

  2013cites this paper
• α-Cells are dispensable in postnatal morphogenesis and maturation of mouse pancreatic islets.

  2013cites this paper
• Regulation of hepatic glucose production by Gq-coupled receptors: potential new targets for treatment of type 2 diabetes.

  2013cites this paper
• Untersuchungen zur Regulation der Genexpression des diabetes-assoziierten Autoantigens ZnT-8 in INS-1- Insulinomazellen

  2012cites this paper
• Discovery of a novel glucagon receptor antagonist N-[(4-{(1S)-1-[3-(3, 5-dichlorophenyl)-5-(6-methoxynaphthalen-2-yl)-1H-pyrazol-1-yl]ethyl}phenyl)carbonyl]-β-alanine (MK-0893) for the treatment of type II diabetes.

  2012cites this paper
• α-cell role in β-cell generation and regeneration

  2012cites this paper
• Rat glucagon receptor mRNA is directly regulated by glucose through transactivation of the carbohydrate response element binding protein.

  2012cites this paper
• Ectopic expression of glucagon receptor in skeletal muscles improves glucose homeostasis in a mouse model of diabetes

  2012cites this paper
• THE ROLE OF CENTRAL GLUCAGON SIGNALING IN THE REGULATION OF GLUCOSE HOMEOSTASIS

  2012cites this paper
• Targeting the glucagon receptor family for diabetes and obesity therapy.

  2012cites this paper
• Differential effects of oxyntomodulin and GLP-1 on glucose metabolism.

  2012cites this paper
• Glucagon and cyclic AMP: time to turn the page?

  2012cites this paper
• The effects of cannabinoids on insulin secretion

  2011cites this paper
• The Role of the GLP-2 Receptor in Intestinal and Islet Adaptation to Changes in Nutrient Availability

  2011cites this paper
• Dual elimination of the glucagon and GLP-1 receptors in mice reveals plasticity in the incretin axis.

  2011cites this paper
• Bone marrow cavity: A supportive environment for islet engraftment

  2011cites this paper
• Glucagon antagonism as a potential therapeutic target in type 2 diabetes

  2011cites this paper
• PANDER KO mice on high‐fat diet are glucose intolerant yet resistant to fasting hyperglycemia and hyperinsulinemia

  2011cites this paper
• The alpha-cell as target for type 2 diabetes therapy.

  2011cites this paper
• Remission of diabetes mellitus in cats cannot be predicted by the arginine stimulation test.

  2011cites this paper